CarlosDFlombaumMD

Nephrology • New York, NY

Associate Professor, Medicine, Weill Cornell Medical College

Join to view full profile

Dr. Flombaum is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Flombaum's full profile

Already have an account?

Office
1275 York Ave
New York, NY 10021
Phone+1 646-227-3813
Is this information wrong?

Summary

I am a clinical nephrologist working at a major cancer center who deals with renal problems associated with cancer and its therapy. I am board certified in Internal Medicine and Nephrology

Education & Training

One Brooklyn Health System/Brookdale University Hospital and Medical CenterFellowship, Nephrology, 1973 - 1975
Coney Island HospitalResidency, Internal Medicine, 1972 - 1972
Maimonides Medical CenterResidency, Internal Medicine, 1971 - 1971
Caritas Health Care (Brooklyn-Queens)Internship, Transitional Year, 1970 - 1970
University of Buenos AiresClass of 1969

Certifications & Licensure

FL State Medical License 1982 - Present
NJ State Medical License 2021 - 2025
NY State Medical License 1974 - 2025
WV State Medical License 1976 - 1977
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Publications & Presentations

PubMed

4 citations
Hypophosphatemia and FGF23 tumor-induced osteomalacia in two cases of metastatic breast cancer.
Matthew Abramson, Ilya G. Glezerman, Maya Srinivasan, Richard Ross, Carlos D. Flombaum, Victoria Gutgarts> ;Clinical Nephrology. 2021 Feb 1
14 citations
Management of Patients with Acute Methotrexate Nephrotoxicity with High-Dose Leucovorin.
Carlos D. Flombaum, Dazhi Liu, Shirley Qiong Yan, Amelia Chan, Sherry Mathew, Paul A. Meyers, Ilya G. Glezerman, Thangamani Muthukumar> ;Pharmacotherapy. 2018 Jul 1
127 citations
Long–Term Renal Outcomes after Cisplatin Treatment
Sheron Latcha, Edgar A. Jaimes, Sujata Patil, Ilya G. Glezerman, Swati Mehta, Carlos D. Flombaum> ;Clinical Journal of the American Society of Nephrology. 2016 Jul 7
43 citations
Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of litera...
Joichi Usui, Ilya G. Glezerman, Steven P. Salvatore, Chandra B. Chandran, Carlos D. Flombaum, Surya V. Seshan> ;Human Pathology. 2014 Sep 1
73 citations
Bortezomib and dexamethasone consolidation following risk-adapted melphalan and stem cell transplantation for patients with newly diagnosed light-chain amyloidosis
Heather Landau, Hani Hassoun, Michael Rosenzweig, Mathew S. Maurer, Jennifer E. Liu, Carlos D. Flombaum, Christina Bello, Elizabeth Hoover, Elyn Riedel, Sergio Giralt,...> ;Leukemia. 2013 Apr 1
26 citations
Long term renal toxicity of ifosfamide in adult patients--5 year data.
James K. Farry, Carlos D. Flombaum, Sheron Latcha> ;European Journal of Cancer. 2012 Jun 1
6 citations
A retrospective observational study on the use of capecitabine in patients with severe renal impairment (GFR <30 mL/min) and end stage renal disease on hemodialysis.
Kenar D. Jhaveri, Carlos D. Flombaum, Manish A. Shah, Sheron Latcha> ;Journal of Oncology Pharmacy Practice. 2012 Mar 1
9 citations
High-dose methotrexate-induced renal dysfunction: is glucarpidase necessary for rescue?
Paul A. Meyers, Carlos D. Flombaum> ;Journal of Clinical Oncology. 2011 Mar 1
33 citations
Nephrotoxicities Associated with the Use of Tyrosine Kinase Inhibitors: A Single-Center Experience and Review of the Literature
Kenar D. Jhaveri, Carlos D. Flombaum, Glenn Kroog, Ilya G. Glezerman> ;Nephron. Clinical Practice. 2010 Nov 3
50 citations
Chronic kidney disease, thrombotic microangiopathy, and hypertension following T cell-depleted hematopoietic stem cell transplantation.
Ilya G. Glezerman, Kenar D. Jhaveri, Thomas H. Watson, Alison M. Edwards, Esperanza B. Papadopoulos, James W. Young, Carlos D. Flombaum, Ann A. Jakubowski> ;Biology of Blood and Marrow Transplantation. 2010 Jul 1
31 citations
Feasibility Trial of Letrozole in Combination With Bevacizumab in Patients With Metastatic Breast Cancer
Tiffany A. Traina, Hope S. Rugo, James F. Caravelli, Sujata Patil, Benjamin M. Yeh, M. Melisko, John W. Park, S. Geneus, Matthew Paulson, Jill Grothusen, Andrew D. Sei...> ;Journal of Clinical Oncology. 2010 Feb 1
241 citations
Phase I Trial of Bevacizumab Plus Escalated Doses of Sunitinib in Patients With Metastatic Renal Cell Carcinoma
Darren R. Feldman, Michael Baum, Michelle S. Ginsberg, Hani Hassoun, Carlos D. Flombaum, Susanne Velasco, Patricia Fischer, Ellen A. Ronnen, Nicole Ishill, Sujata Pati...> ;Journal of Clinical Oncology. 2009 Mar 20
67 citations
Gemcitabine nephrotoxicity and hemolytic uremic syndrome: report of 29 cases from a single institution.
Ilya G. Glezerman, Mark G. Kris, Vincent A. Miller, Surya V. Seshan, Carlos D. Flombaum> ;Clinical Nephrology. 2009 Feb 1
5 citations
Ifosfamide May Be Safely Used in Patients with End Stage Renal Disease on Hemodialysis
Sheron Latcha, Robert G. Maki, Gary K. Schwartz, Carlos D. Flombaum> ;Sarcoma. 2009 Jan 1
43 citations
High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease.
Hani Hassoun, Carlos D. Flombaum, Vivette D. D'Agati, B T Rafferty, Adam D. Cohen, Virginia M. Klimek, Adam Boruchov, Tarun Kewalramani, L Reich, Stephen D. Nimer, Ray...> ;Bone Marrow Transplantation. 2008 Jun 23
3 citations
Sirolimus (rapamycin) induced proteinuria in a patient undergoing allogeneic hematopoietic stem cell transplant.
Kenar D. Jhaveri, Jonathan H. Schatz, James W. Young, Carlos D. Flombaum> ;Transplantation. 2008 Jul 15
170 citations
Cetuximab Therapy and Symptomatic Hypomagnesemia
Deborah Schrag, Ki Y. Chung, Carlos D. Flombaum, Leonard B. Saltz> ;Journal of the National Cancer Institute. 2005 Aug 17
72 citations
Efforts to control the errant products of a targeted in vivo generator.
Jaspreet Singh Jaggi, Barry J. Kappel, Michael R. McDevitt, George Sgouros, Carlos D. Flombaum, Catalina Cabassa, David A. Scheinberg> ;Cancer Research. 2005 Jun 1
75 citations
Acute renal failure in cancer patients
Norbert Lameire, Carlos D. Flombaum, Delphine Moreau, Claudio Ronco> ;Annals of Medicine. 2005 Jan 1
3 citations
High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma.
Michael J Morris, Oren Smaletz, David Solit, W Kevin Kelly, Susan Slovin, Carlos Flombaum, Tracy Curley, Anthony Delacruz, Lawrence Schwartz, Martin Fleisher, Andrew Z...> ;Cancer. 2004 May 1
98 citations
Metabolic emergencies in the cancer patient.
Carlos D. Flombaum> ;Seminars in Oncology. 2000 Jun 1
138 citations
Sequential Dose-Intensive Paclitaxel, Ifosfamide, Carboplatin, and Etoposide Salvage Therapy for Germ Cell Tumor Patients
Robert J. Motzer, Madhu Mazumdar, Joel Sheinfeld, Dean F. Bajorin, Homer A. Macapinlac, Manjit S. Bains, Lilian Reich, Carlos D. Flombaum, Tania Mariani, William P. To...> ;Journal of Clinical Oncology. 2000 Mar 13
71 citations
High-Dose Leucovorin as Sole Therapy for Methotrexate Toxicity
Carlos D. Flombaum, Paul A. Meyers> ;Journal of Clinical Oncology. 1999 May 1
61 citations
Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine
Carlos D. Flombaum, Janet Mouradian, Ephraim S. Casper, Robert A. Erlandson, Fabio Benedetti> ;American Journal of Kidney Diseases. 1999 Mar 1
29 citations
Septicemia and septic shock in pediatric patients : 140 consecutive cases on a pediatric hematology-oncology service
Alexander Aledo, Glenn Heller, Leigh Ren, Sharon Gardner, Ira J. Dunkel, Shelley W. McKay, Carlos D. Flombaum, Arthur E. Brown> ;Journal of Pediatric Hematology/oncology. 1998 May 1
Join now to see all

Hospital Affiliations

Memorial Sloan Kettering Cancer CenterNew York, New York

CarlosDFlombaumMD

Dr. Flombaum is on Doximity

Summary

Education & Training

Certifications & Licensure

Publications & Presentations

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.